Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023

SELL
$0.5 - $1.05 $9,504 - $19,959
-19,009 Reduced 57.09%
14,285 $8,000
Q2 2023

Aug 08, 2023

SELL
$0.55 - $0.89 $322,175 - $521,338
-585,774 Reduced 94.62%
33,294 $25,000
Q1 2023

May 11, 2023

BUY
$0.68 - $1.25 $17,044 - $31,331
25,065 Added 4.22%
619,068 $440,000
Q4 2022

Feb 14, 2023

BUY
$0.96 - $1.34 $18,038 - $25,178
18,790 Added 3.27%
594,003 $612,000
Q3 2022

Nov 10, 2022

BUY
$1.02 - $2.23 $55,099 - $120,462
54,019 Added 10.36%
575,213 $759,000
Q2 2022

Aug 11, 2022

BUY
$0.94 - $1.94 $76,713 - $158,323
81,610 Added 18.57%
521,194 $537,000
Q1 2022

May 12, 2022

BUY
$1.54 - $3.71 $17,669 - $42,568
11,474 Added 2.68%
439,584 $866,000
Q4 2021

Feb 10, 2022

SELL
$2.58 - $3.91 $10,118 - $15,335
-3,922 Reduced 0.91%
428,110 $1.14 Million
Q3 2021

Nov 12, 2021

BUY
$2.77 - $4.05 $24,021 - $35,121
8,672 Added 2.05%
432,032 $1.47 Million
Q2 2021

Aug 05, 2021

BUY
$1.71 - $4.14 $723,945 - $1.75 Million
423,360 New
423,360 $1.63 Million
Q2 2020

Aug 13, 2020

SELL
$0.39 - $0.69 $57,937 - $102,505
-148,558 Closed
0 $0
Q1 2020

May 06, 2020

SELL
$0.56 - $1.62 $10,920 - $31,590
-19,500 Reduced 11.6%
148,558 $94,000
Q4 2019

Feb 05, 2020

BUY
$0.83 - $1.3 $14,075 - $22,045
16,958 Added 11.22%
168,058 $154,000
Q3 2019

Oct 23, 2019

BUY
$0.97 - $1.94 $2,842 - $5,684
2,930 Added 1.98%
151,100 $149,000
Q2 2019

Aug 14, 2019

BUY
$1.81 - $2.45 $72,906 - $98,686
40,280 Added 37.33%
148,170 $302,000
Q1 2019

May 01, 2019

SELL
$2.3 - $3.27 $1,313 - $1,867
-571 Reduced 0.53%
107,890 $264,000
Q4 2018

Jan 31, 2019

BUY
$2.49 - $4.54 $104,565 - $190,652
41,994 Added 63.18%
108,461 $281,000
Q3 2018

Nov 07, 2018

BUY
$3.4 - $4.84 $14,650 - $20,855
4,309 Added 6.93%
66,467 $317,000
Q2 2018

Aug 06, 2018

BUY
$3.03 - $4.98 $188,338 - $309,546
62,158 New
62,158 $255,000

Others Institutions Holding SENS

About Senseonics Holdings, Inc.


  • Ticker SENS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 465,447,008
  • Market Cap $475M
  • Description
  • Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...
More about SENS
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.